Transaera, Inc. | $10,500,000 | (Nov 5, 2024)
Algebrik AI | $4,000,000 | (Nov 5, 2024)
Further | $4,100,000 | (Nov 5, 2024)
Aelius Biotech
United Kingdom
- Newcastle upon Tyne, Tyne and Wear
- 28/11/2023
- Unknown
- $1,578,000
Aelius biotech specialise in the development of models of the mucosal surfaces of the human body. We currently have the capability to model the gastrointestinal tract and the airways, and are in the process of developing model systems to simulate the mucosal surfaces of the eye and cervico-vaginal tract.
- Industry Research Services
- Website https://aeliusbiotech.co.uk/
- LinkedIn https://www.linkedin.com/company/aelius-biotech/about/
Related People
Peter ChaterCo Founder
United Kingdom -
Newcastle upon Tyne, England
At Aelius Biotech we develop and use in vitro models of the aero-digestive tract to help our collaborators and customers test and develop new formulations, drug delivery systems and functional foods.
We've developed the first in vitro system to model the processes of digestion, mucus permeation and epithelial absorption in a single lab system, and have shown how this can be used as an effective screening/development tool for oral formulations. Send me a message if you want more information.
Cintoo | $40,246,701 | (Nov 5, 2024)
Advex AI | $3,500,000 | (Nov 5, 2024)
Insider. | $500,000,000 | (Nov 5, 2024)
OpenOrigins | $4,500,000 | (Nov 1, 2024)
MealMe, Inc. | $8,000,000 | (Nov 1, 2024)
Persperity Health, Inc | $1,000,000 | (Nov 1, 2024)
Persana AI | $2,300,000 | (Nov 1, 2024)
Definition Health | $7,412,756 | (Nov 1, 2024)